Matsukawa T - Search Results

1

Sequential changes in urinary catecholamine in the transition from benign to malignant hypertension in rats.

Sesoko S, Iwasawa H, Akema N, Matsukawa T, Sugiyama K, Shionoiri H, Kaneko Y. Sesoko S, et al. Among authors: matsukawa t. Jpn Circ J. 1988 Feb;52(2):197-202. doi: 10.1253/jcj.52.197. Jpn Circ J. 1988. PMID: 3361705

2

Predisposing factors for the development of malignant essential hypertension.

Sesoko S, Akema N, Matsukawa T, Kaneko Y. Sesoko S, et al. Among authors: matsukawa t. Arch Intern Med. 1987 Oct;147(10):1721-4. Arch Intern Med. 1987. PMID: 3662703

3

Augmented sympathetic nerve activity in response to stressors in young borderline hypertensive men.

Matsukawa T, Gotoh E, Uneda S, Miyajima E, Shionoiri H, Tochikubo O, Ishii M. Matsukawa T, et al. Acta Physiol Scand. 1991 Feb;141(2):157-65. doi: 10.1111/j.1748-1716.1991.tb09064.x. Acta Physiol Scand. 1991. PMID: 2048404

4

Reduced reflex sympathoinhibition in adolescents with hypertensive parents.

Miyajima E, Yamada Y, Matsukawa T, Uneda S, Shionoiri H, Tochikubo O. Miyajima E, et al. Among authors: matsukawa t. Jpn Circ J. 1988 Nov;52(11):1335-7. doi: 10.1253/jcj.52.1335. Jpn Circ J. 1988. PMID: 3225900 No abstract available.

5

Impaired baroreflex changes in muscle sympathetic nerve activity in adolescents who have a family history of essential hypertension.

Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Shionoiri H, Ishii M, Kaneko Y. Yamada Y, et al. Among authors: matsukawa t. J Hypertens Suppl. 1988 Dec;6(4):S525-8. doi: 10.1097/00004872-198812040-00165. J Hypertens Suppl. 1988. PMID: 3241250

6

[Sequential changes in urinary catecholamine in the transition from benign to malignant hypertension in rats].

Sesoko S, Iwasawa H, Akema N, Matsukawa T, Sugiyama K, Kaneko Y. Sesoko S, et al. Among authors: matsukawa t. Nihon Jinzo Gakkai Shi. 1988 Feb;30(2):169-74. Nihon Jinzo Gakkai Shi. 1988. PMID: 3386021 Japanese. No abstract available.

7

Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension.

Matsukawa T, Gotoh E, Hasegawa O, Shionoiri H, Tochikubo O, Ishii M. Matsukawa T, et al. J Hypertens. 1991 Jun;9(6):537-42. doi: 10.1097/00004872-199106000-00009. J Hypertens. 1991. PMID: 1653293

8

Angiotensin II inhibits baroreflex control of muscle sympathetic nerve activity and the heart rate in patients with essential hypertension.

Matsukawa T, Gotoh E, Miyajima E, Yamada Y, Shionoiri H, Tochikubo O, Ishii M. Matsukawa T, et al. J Hypertens Suppl. 1988 Dec;6(4):S501-4. doi: 10.1097/00004872-198812040-00158. J Hypertens Suppl. 1988. PMID: 3241243

9

[Predisposing factors for the development of malignant essential hypertension].

Sesoko S, Sugiyama K, Akema N, Matsukawa T, Kaneko Y. Sesoko S, et al. Among authors: matsukawa t. Nihon Naika Gakkai Zasshi. 1987 Nov;76(11):1690-4. doi: 10.2169/naika.76.1690. Nihon Naika Gakkai Zasshi. 1987. PMID: 3509169 Japanese. No abstract available.

10

Pharmacokinetics and antihypertensive effects of lisinopril in hypertensive patients with normal and impaired renal function.

Shionoiri H, Minamisawa K, Ueda S, Abe Y, Ebina T, Sugimoto K, Matsukawa T, Gotoh E, Ishii M. Shionoiri H, et al. Among authors: matsukawa t. J Cardiovasc Pharmacol. 1990 Oct;16(4):594-600. doi: 10.1097/00005344-199010000-00010. J Cardiovasc Pharmacol. 1990. PMID: 1706800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters